Division of Cardiology, Department of Internal Medicine, Changhua Christian Hospital, Yunlin Branch, Yunlin, Taiwan.
Department of Nursing, Hungkuang University, Taichung, Taiwan.
Int J Med Sci. 2024 Oct 28;21(14):2851-2861. doi: 10.7150/ijms.103186. eCollection 2024.
Diabetic kidney disease (DKD) is the gradual loss of renal function occurring in patients with diabetes. Stromal cell-derived factor-1 (SDF-1, encoded by gene) is a chemokine that binds to its receptor, CXCR4, to mediate many aspects of renal biology. To test the potential impact of gene variations on the risk for DKD, single-nucleotide polymorphisms (SNPs) of genes were genotyped in 388 DKD patients and 335 DKD-free diabetic controls. Among 6 SNPs examined, we demonstrated that rs1801157 of gene was associated with an increased risk for DKD (GA vs GG, AOR=2.252, =0.035; GA+AA vs GG, AOR=2.156, =0.036). Further stratification revealed that the correlation of rs1801157 with DKD was particularly detected in diabetic patients with early CKD but not in those with severe renal impairment. Instead, another SNP of gene, rs266085, was found in association with the advanced form of DKD (TC vs TT, AOR=2.106, =0.027; TC+CC vs TT, AOR=2.130, =0.019), indicating differential impacts of gene polymorphisms on the progressive loss of renal function in diabetic patients. Moreover, preliminary survey of public gene expression datasets showed that rs1801157 and rs266085 modulated expression in many human tissues, and SDF-1/CXCR4 levels were elevated in renal tissues of DKD patients. These data suggest that allele-specific expression of gene may influence DKD progression.
糖尿病肾病(DKD)是糖尿病患者肾功能逐渐丧失的一种疾病。基质细胞衍生因子-1(SDF-1,由 基因编码)是一种趋化因子,它与受体 CXCR4 结合,介导肾脏生物学的许多方面。为了测试 基因变异对 DKD 风险的潜在影响,对 388 名 DKD 患者和 335 名无 DKD 的糖尿病对照者的 基因单核苷酸多态性(SNPs)进行了基因分型。在研究的 6 个 SNP 中,我们证明 基因的 rs1801157 与 DKD 风险增加相关(GA 与 GG,OR=2.252,=0.035;GA+AA 与 GG,OR=2.156,=0.036)。进一步分层显示,rs1801157 与 DKD 的相关性尤其在早期 CKD 的糖尿病患者中检测到,但在严重肾功能不全的患者中未检测到。相反, 基因的另一个 SNP rs266085 与 DKD 的晚期形式有关(TC 与 TT,OR=2.106,=0.027;TC+CC 与 TT,OR=2.130,=0.019),表明 基因多态性对糖尿病患者肾功能进行性丧失的影响不同。此外,对公共基因表达数据集的初步调查显示,rs1801157 和 rs266085 调节了 基因在许多人类组织中的表达,并且 DKD 患者的肾脏组织中 SDF-1/CXCR4 水平升高。这些数据表明, 基因的等位基因特异性表达可能影响 DKD 的进展。